Stratigos A, Sekulic A, Peris K, Bechter O, Kaatz M, Lewis K, Basset-Segiun N, Chang AL, Dalle S, Orland AF, Licitra L, Robert C, Ulrich C, Hauschild A, Migden M, Dummer R, Li S, Mohan K, Coates E, Jankovic V, Flaschi N, Okoye E, Bassukas I, Loquai C, De Giorgi V, Eroglu Z, Gutzmer R, Ulrich J, Puig S, Seebach F, Thurston G, Lowy I, Bowler T, Fury M. Primary Analysis of Phase 2 Results for Cemiplimab in Patients (pts) with Locally Advanced Basal Cell Carcinoma (laBCC) who Progress on or are Intolerant to Hedgehog Inhibitors (HHIs). J of Skin [Internet]. 2021 Jan. 1 [cited 2024 Jul. 4];5(1):s4. Available from: https://jofskin.org/33014/index.php/skin/article/view/1156